Literature DB >> 6808549

Increased food intake following the manipulation of intracerebral dopamine levels with gamma-hydroxybutyrate.

P Redgrave, E B Taha, L White, P Dean.   

Abstract

The administration of gamma-hydroxybutyric acid (GHB) initially causes a temporary "sleep-like" state during which there is an increase in forebrain dopamine levels. The present series of experiments examined whether in the period following the GHB-induced behavioural depression, when accumulated dopamine is dispersed, there is any behavioural evidence of increased dopaminergic activity. The first experiment, in which GHB was injected directly into the cerebral ventricles, demonstrated that in the immediate post-recovery period rats exhibited various forms of stereotyped oral behaviour and stereotyped sniffing. Unexpectedly, it was also observed that if food were present animals preferred to eat. The nature of this feeding response was examined in two further experiments. Firstly, it was shown that in the period following the behavioural depression animals would perform, in a dose-dependent fashion, an operant response which was rewarded by food. Secondly, the GHB-induced increase in feeding was abolished by the pre-treatment of animals with either the dopamine synthesis inhibitor alpha-methyl-p-tyrosine, or the dopamine receptor blocker haloperidol. These data indicate that (i) in the period when it is known that the GHB-induced accumulation of dopamine is dispersing, there is behavioural evidence of increased dopaminergic activity; (ii) the feeding response is not a simple oral reflex; and (iii) in addition to being essential for food intake dopaminergic transmission may play a direct role in the production of feeding.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6808549     DOI: 10.1007/BF00432560

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Feeding and drinking interactions after acute butyrophenone administration.

Authors:  N Rowland; D J Engle
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

Review 2.  A systematic study of the pharmacological activities of dopamine antagonists.

Authors:  C J Niemegeers; P A Janssen
Journal:  Life Sci       Date:  1979-06-11       Impact factor: 5.037

Review 3.  Gamma hydroxybutyrate.

Authors:  O C Snead
Journal:  Life Sci       Date:  1977-06-15       Impact factor: 5.037

4.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

5.  Nigrostriatal bundle damage and the lateral hypothalamic syndrome.

Authors:  J F Marshall; J S Richardson; P Teitelbaum
Journal:  J Comp Physiol Psychol       Date:  1974-11

6.  Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.

Authors:  J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

7.  Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum.

Authors:  J R Walters; R H Roth
Journal:  Biochem Pharmacol       Date:  1972-08-01       Impact factor: 5.858

8.  Stereotyped activities produced by amphetamine in several animal species and man.

Authors:  A Randrup; I Munkvad
Journal:  Psychopharmacologia       Date:  1967

9.  The effect of gamma-butyrolactone on locomotor activity in the rat.

Authors:  J A Davies
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

10.  A methodological approach to rapid and sensitive monoamine histofluorescence using a modified glyoxylic acid technique: the SPG method.

Authors:  J C Torre; J W Surgeon
Journal:  Histochemistry       Date:  1976-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.